Literature DB >> 19359116

Mammography and breast sonography in transsexual women.

S Weyers1, G Villeirs, E Vanherreweghe, H Verstraelen, S Monstrey, R Van den Broecke, J Gerris.   

Abstract

Data on the necessity of performing screening mammographies in transsexual women are lacking. The main objective of this study was to assess the possibility to perform mammography and breast sonography in transsexual women. Fifty Dutch-speaking transsexual women were interviewed about the following: attitude towards mammography and breast sonography, importance attributed to and satisfaction with breast appearance, opinion about the necessity of breast check-up, expectations regarding discomfort during the exams and knowledge about the breast surgery. A fasting blood sample, clinical breast exam, mammography and breast sonography were performed. At mammography the following parameters were noted: density, technical quality, location of the prostheses, presence of any abnormalities and painfulness. At sonography the following parameters were recorded: density, presence of cysts, visualisation of retro-areolar ducts or any abnormalities. Twenty-three percent of patients are not aware of the type of breast implants and 79% do not know their position to the pectoral muscles. Patient satisfaction with the appearance of their breasts was rather high (7.94 on a scale of 0-10). Mean expected and experienced pain from mammography was low (4.37 and 2.00 respectively). There was no statistically significant difference in expected pain between those who already had mammography and those who did not. There was a significant positive correlation between the expected and the experienced pain. Mammography and breast sonography were technically feasible and no gross anomalies were detected. Since both exams were judged as nearly painless, 98% of transsexual women intended to come back if they would be invited. Since breast cancer risk in transsexual women is largely unknown and breast exams are very well accepted, breast screening habits in this population should not differ from those of biological women. Copyright (c) 2009 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2009        PMID: 19359116     DOI: 10.1016/j.ejrad.2009.03.018

Source DB:  PubMed          Journal:  Eur J Radiol        ISSN: 0720-048X            Impact factor:   3.528


  7 in total

1.  Breast cancer in male-to-female (MtF) transgender patients: is hormone receptor negativity a feature?

Authors:  Zhi Hao Teoh; David Archampong; Tim Gate
Journal:  BMJ Case Rep       Date:  2015-05-20

2.  Breast cancer risk and breast screening for trans people: an integration of 3 systematic reviews.

Authors:  Olivia Meggetto; Leslea Peirson; Mafo Yakubu; Mufiza Farid-Kapadia; Michelle Costa-Fagbemi; Shamara Baidoobonso; Jessica Moffatt; Lauren Chun; Anna M Chiarelli; Derek Muradali
Journal:  CMAJ Open       Date:  2019-10-01

3.  Standards of Care for the Health of Transgender and Gender Diverse People, Version 8.

Authors:  E Coleman; A E Radix; W P Bouman; G R Brown; A L C de Vries; M B Deutsch; R Ettner; L Fraser; M Goodman; J Green; A B Hancock; T W Johnson; D H Karasic; G A Knudson; S F Leibowitz; H F L Meyer-Bahlburg; S J Monstrey; J Motmans; L Nahata; T O Nieder; S L Reisner; C Richards; L S Schechter; V Tangpricha; A C Tishelman; M A A Van Trotsenburg; S Winter; K Ducheny; N J Adams; T M Adrián; L R Allen; D Azul; H Bagga; K Başar; D S Bathory; J J Belinky; D R Berg; J U Berli; R O Bluebond-Langner; M-B Bouman; M L Bowers; P J Brassard; J Byrne; L Capitán; C J Cargill; J M Carswell; S C Chang; G Chelvakumar; T Corneil; K B Dalke; G De Cuypere; E de Vries; M Den Heijer; A H Devor; C Dhejne; A D'Marco; E K Edmiston; L Edwards-Leeper; R Ehrbar; D Ehrensaft; J Eisfeld; E Elaut; L Erickson-Schroth; J L Feldman; A D Fisher; M M Garcia; L Gijs; S E Green; B P Hall; T L D Hardy; M S Irwig; L A Jacobs; A C Janssen; K Johnson; D T Klink; B P C Kreukels; L E Kuper; E J Kvach; M A Malouf; R Massey; T Mazur; C McLachlan; S D Morrison; S W Mosser; P M Neira; U Nygren; J M Oates; J Obedin-Maliver; G Pagkalos; J Patton; N Phanuphak; K Rachlin; T Reed; G N Rider; J Ristori; S Robbins-Cherry; S A Roberts; K A Rodriguez-Wallberg; S M Rosenthal; K Sabir; J D Safer; A I Scheim; L J Seal; T J Sehoole; K Spencer; C St Amand; T D Steensma; J F Strang; G B Taylor; K Tilleman; G G T'Sjoen; L N Vala; N M Van Mello; J F Veale; J A Vencill; B Vincent; L M Wesp; M A West; J Arcelus
Journal:  Int J Transgend Health       Date:  2022-09-06

4.  Perceptions of and barriers to cancer screening by the sexual and gender minority community: a glimpse into the health care disparity.

Authors:  Joseph Lombardo; Kevin Ko; Ayako Shimada; Nicolas Nelson; Christopher Wright; Jerry Chen; Alisha Maity; Marissa L Ruggiero; Scott Richard; Dimitrios Papanagnou; Edith Mitchell; Amy Leader; Nicole L Simone
Journal:  Cancer Causes Control       Date:  2022-01-04       Impact factor: 2.532

Review 5.  Cancer in Sexual and Gender Minority Patients: Are We Addressing Their Needs?

Authors:  Elizabeth J Cathcart-Rake
Journal:  Curr Oncol Rep       Date:  2018-09-13       Impact factor: 5.075

Review 6.  Gynaecological aspects of the treatment and follow-up of transsexual men and women.

Authors:  S Weyers; P De Sutter; S Hoebeke; G Monstrey; G 'T Sjoen; H Verstraelen; J Gerris
Journal:  Facts Views Vis Obgyn       Date:  2010

Review 7.  Breast Imaging of Transgender Individuals: A Review.

Authors:  Emily B Sonnenblick; Ami D Shah; Zil Goldstein; Tamar Reisman
Journal:  Curr Radiol Rep       Date:  2018-01-18
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.